BPAMU
GILD icon

BTG Pactual Asset Management US’s Gilead Sciences GILD Stock Holding History

BTG Pactual Asset Management US’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,691
Closed -$330K – 365
2025
Q4 		$330K Buy
+2,691
New +$327K 0.03% 150

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BTG Pactual Asset Management US's GILD Position: Q1 2026 in Review

BTG Pactual Asset Management US sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 2,691 shares — an estimated $330K sold.

BTG Pactual Asset Management US first reported a position in GILD in Q4 2025 and held it in 1 quarter. The position peaked at $330K in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • BTG Pactual Asset Management US reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • BTG Pactual Asset Management US sold 2,691 Gilead Sciences shares in Q1 2026, an estimated $330K.
  • BTG Pactual Asset Management US first reported a position in Gilead Sciences in Q4 2025 and held it in 1 quarter.
  • BTG Pactual Asset Management US's Gilead Sciences position peaked at $330K in Q4 2025.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.